In the BioHarmony Drug Report Database
Bretylium
Bretylium Tosylate, Bretylol (bretylium) is a small molecule pharmaceutical. Bretylium was first approved as Bretylium Tosylate on 1982-01-01. It is used to treat ventricular fibrillation and ventricular tachycardia in the USA.
Trade Name
|
Bretylium Tosylate, Bretylol |
|---|---|
Common Name
|
bretylium |
ChEMBL ID
|
CHEMBL1199080 |
Indication
|
ventricular fibrillation, ventricular tachycardia |
Drug Class
|
Quaternary ammonium derivatives |
Image (chem structure or protein)